Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scynexis (SCYX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Scynexis (SCYX) over the last 13 years, with Q3 2025 value amounting to $37.9 million.

  • Scynexis' Cash & Equivalents fell 5535.92% to $37.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $37.9 million, marking a year-over-year decrease of 5535.92%. This contributed to the annual value of $16.1 million for FY2024, which is 5286.05% down from last year.
  • Latest data reveals that Scynexis reported Cash & Equivalents of $37.9 million as of Q3 2025, which was down 5535.92% from $46.5 million recorded in Q2 2025.
  • In the past 5 years, Scynexis' Cash & Equivalents ranged from a high of $118.7 million in Q2 2022 and a low of $16.1 million during Q4 2024
  • Moreover, its 5-year median value for Cash & Equivalents was $91.9 million (2023), whereas its average is $77.3 million.
  • As far as peak fluctuations go, Scynexis' Cash & Equivalents soared by 35430.8% in 2021, and later tumbled by 5615.21% in 2022.
  • Scynexis' Cash & Equivalents (Quarter) stood at $104.5 million in 2021, then tumbled by 56.15% to $45.8 million in 2022, then dropped by 25.68% to $34.0 million in 2023, then tumbled by 52.86% to $16.1 million in 2024, then surged by 136.12% to $37.9 million in 2025.
  • Its Cash & Equivalents stands at $37.9 million for Q3 2025, versus $46.5 million for Q2 2025 and $53.8 million for Q1 2025.